$ALLO – Shortest latest analysis (May 29-31, 2026)

The ticker: Most "ALLO" chatter is actually two things — Allogene Therapeutics Inc (NASDAQ: ALLO) biotech stock, and $ALLO token crypto. Here's both:

1. Allogene Therapeutics Inc (ALLO) Stock • Price: $2.17, down 3.56% on May 29. After-hours: $2.18, +0.60% • 52-week range: $0.98 - $4.46. Up 90% YoY, but down 0.44% this month • Analyst consensus: Moderate Buy from 13 analysts: 1 Sell, 3 Hold, 8 Buy, 1 Strong Buy • Price target: Avg $8.52, range $3.85-$14.00 → ∼293% upside to avg target • Fundamentals: Market cap ∼$755M, -2.82 P/E, -$0.72 EPS est this year. Clinical-stage biotech, no revenue • Next earnings: Est Aug 12, 2026

Bottom line: High-risk biotech. Analysts like it vs peers, but it’s pre-revenue and volatile: beta 0.45, but TradingView shows beta 1.93

2. $ALLO Crypto Token – “PORTAL/GENIUS” context

Social traders were hyping ALLOUSDT perps on Binance/Bybit this week:

• Bearish flip: Mastering Crypto called a short after $0.197 resistance failed. Entry $0.195-$0.225, stop $0.24, targets down to $0.14. RSI >93, overbought • Bullish breakouts: Multiple swing-long setups posted May 28-29. Entries ∼$0.095-$0.1125, 25x-50x lev, targets $0.102-$0.1185 • Current shorts: Several traders shorting at $0.2620 with targets $0.25-$0.21, stop $0.3388

Sentiment split: Chart went parabolic to $0.163, +111%, but RSI extreme. Bears now targeting correction to MA25/MA99

Key risk: This is crypto perps with 25x-50x leverage. High noise, pump/dump signals common.

Want me to pull $ALLO’s latest biotech catalysts or check the crypto chart live?#Cardano2026SummitCanceled #NomuraLaserOCCTrustApproval